Table 1 Clinical data on the volume of bone-filling material in procedures using Bio-Oss® and Cytrans®
Treatment group | Patient no. | Age | Gender | Deficit condition (FDI) | T2 (ml) | T3 (ml) | Absorbed amount (%) |
|---|---|---|---|---|---|---|---|
Bio-Oss® (n = 8) | 1 | 65 | F | Edentulous | 3.762 | 2.538 | 32.50 |
2 | 59 | M | 23–27 | 1.583 | 1.167 | 26.30 | |
3 | 53 | M | 26, 27 | 2.271 | 1.772 | 22.00 | |
4 | 59 | F | 14–17 | 4.880 | 3.836 | 21.40 | |
5 | 21 | F | 14–16 | 1.428 | 0.916 | 35.90 | |
6 | 70 | F | 26, 27 | 2.163 | 1.622 | 25.00 | |
7 | 71 | F | Edentulous | 2.436 | 1.973 | 19.00 | |
8 | 71 | F | Edentulous | 3.198 | 2.581 | 19.30 | |
Cytrans® (n = 6) | 1 | 67 | F | 14–17 | 2.547 | 2.371 | 6.90 |
2 | 41 | F | 16, 17 | 2.108 | 1.791 | 15.00 | |
3 | 59 | M | 25–27 | 1.506 | 1.222 | 18.90 | |
4 | 67 | M | Edentulous | 3.763 | 3.375 | 10.30 | |
5 | 67 | M | Edentulous | 2.392 | 2.150 | 10.10 | |
6 | 67 | F | 24–27 | 2.780 | 2.386 | 14.20 |